Advertise
NEWSLETTER
HCW Biologics wins key U.S....
Scribe Therapeutics starts ...
Rapalogix Health opens Prin...
China approves Leqembi subc...
FibroBiologics granted US p...
HCW Biologics wins key U.S....
Scribe Therapeutics starts ...
Rapalogix Health opens Prin...
China approves Leqembi subc...
FibroBiologics granted US p...
Dina Radenkovic

Gameto lands $44m to advance fertility and menopause programs

Gameto lands ARPA-H funding to combat menopause with cell therapy

Celebrating International Women’s Day, we reflect on just some of the pioneering women we have written about over the last few months.

International Women’s Day: the wonderful women of longevity

It's game on for Gameto, a new type of biotech company in female reproductive longevity that's aiming to solve the problem of accelerated ovarian aging and change the trajectory of women's health and equality.

Gameto: $23m gamechanger for female reproductive fertility is born

Dr Dina Radenkovic says that targeting menopause is as much about extending female healthspan as it is about fertility.

Gameto founder talks menopause and female healthspan extension

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form